N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid
London, 6th March 2022 – LIfT BioSciences,a biotech bringing to market a first-in-class allogeneic innate cell therapy, today announces...
top of page
LATEST NEWS
- Jan 21, 2022
LIfT BioSciences secures its largest financing to date with a further £5m
London, 21st January 2022 – Biotech LIfT BioSciences today announced its largest financing round to date with a further £5m investment...
- Mar 26, 2021
LIfT BioSciences & King’s College London embark on an exciting new collaboration
London, 26 March – LIfT BioSciences announced today that they have embarked on a collaboration with King’s College London, under the...
bottom of page